Home > Videos > Aortic Valve Replacement > Breaking News: 4-Year Medtronic Low-Risk TAVR Clinical Trial Results

Breaking News: 4-Year Medtronic Low-Risk TAVR Clinical Trial Results

Learn new medical findings and insights from the Medtronic Evolut Low-Risk Clinical Trial in this special interview with Dr. Michael Reardon, Professor of Cardiovascular Surgery at Houston Methodist in Houston, Texas, and Co-Principal Investigator of the Medtronic Evolut Low-Risk TAVR Clinical Trial. (Video posted on May 28, 2024)

Doctor Interviewed

Dr. Michael Reardon, Professor of Cardiovascular Surgery

Dr. Michael Reardon

Professor of Cardiovascular Surgery

Houston Methodist

Houston, Texas

(‍713) 441-5200 (713) 441-5200

Related Videos

Patient Webinar: SAVR vs TAVR Patient Webinar: SAVR vs TAVR
Important Patient Update: Stroke Risk & TAVR Important Patient Update: Stroke Risk & TAVR
Surgeon Q&A: How Does Aortic Valve Replacement Size Impact TAVR Reoperations? Surgeon Q&A: How Does Aortic Valve Replacement Size Impact TAVR Reoperations?

Video Categories

Adam's Updates
Aneurysms
Aortic Stenosis
Aortic Valve Repair
Aortic Valve Replacement
Atrial Fibrillation
Before Surgery
Bicuspid Aortic Valve
Heart Valve Replacement
Medical Technology
Mitral Regurgitation
Mitral Valve Repair
Patient Stories
Pulmonary Valve
Recovery
Ross Procedure
Surgeons & Hospitals
Tricuspid Valve